Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 12393514)

1.

Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors.

Kymäläinen H, Appelt JU, Giordano FA, Davies AF, Ogilvie CM, Ahmed SG, Laufs S, Schmidt M, Bode J, Yáñez-Muñoz RJ, Dickson G.

Hum Gene Ther. 2014 May;25(5):428-42. doi: 10.1089/hum.2013.172. Epub 2014 Apr 10.

2.

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.

Awe JP, Lee PC, Ramathal C, Vega-Crespo A, Durruthy-Durruthy J, Cooper A, Karumbayaram S, Lowry WE, Clark AT, Zack JA, Sebastiano V, Kohn DB, Pyle AD, Martin MG, Lipshutz GS, Phelps PE, Pera RA, Byrne JA.

Stem Cell Res Ther. 2013 Jul 26;4(4):87. doi: 10.1186/scrt246.

3.

Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes.

Smith BA, Shelton DN, Kieffer C, Milash B, Usary J, Perou CM, Bernard PS, Welm BE.

Genes Cancer. 2012 Sep;3(9-10):550-63. doi: 10.1177/1947601913475359.

4.

Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.

Greene MR, Lockey T, Mehta PK, Kim YS, Eldridge PW, Gray JT, Sorrentino BP.

Hum Gene Ther Methods. 2012 Oct;23(5):297-308. doi: 10.1089/hgtb.2012.150. Epub 2012 Nov 7.

5.

Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.

Verhoeyen E, Relouzat F, Cambot M, Costa C, Nègre D, Legrand F, Joubert C, Le Grand R, Cosset FL, Leboulch P, Dubart-Kupperschmitt A, Prost S.

Hum Gene Ther. 2012 Jul;23(7):754-68. doi: 10.1089/hum.2012.020. Epub 2012 Jul 11.

6.
7.

Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity.

Suerth JD, Maetzig T, Brugman MH, Heinz N, Appelt JU, Kaufmann KB, Schmidt M, Grez M, Modlich U, Baum C, Schambach A.

Mol Ther. 2012 May;20(5):1022-32. doi: 10.1038/mt.2011.309. Epub 2012 Feb 14.

8.

CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder.

Calias P, Papisov M, Pan J, Savioli N, Belov V, Huang Y, Lotterhand J, Alessandrini M, Liu N, Fischman AJ, Powell JL, Heartlein MW.

PLoS One. 2012;7(1):e30341. doi: 10.1371/journal.pone.0030341. Epub 2012 Jan 18.

9.

Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex.

Zhao N, Qi J, Zeng Z, Parekh P, Chang CC, Tung CH, Zu Y.

J Control Release. 2012 Apr 10;159(1):104-10. doi: 10.1016/j.jconrel.2012.01.007. Epub 2012 Jan 15.

10.

Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.

Charrier S, Ferrand M, Zerbato M, Précigout G, Viornery A, Bucher-Laurent S, Benkhelifa-Ziyyat S, Merten OW, Perea J, Galy A.

Gene Ther. 2011 May;18(5):479-87. doi: 10.1038/gt.2010.163. Epub 2010 Dec 16.

11.

Mammalian cell transfection: the present and the future.

Kim TK, Eberwine JH.

Anal Bioanal Chem. 2010 Aug;397(8):3173-8. doi: 10.1007/s00216-010-3821-6. Epub 2010 Jun 13. Review.

12.

Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression.

Trinh AT, Ball BG, Weber E, Gallaher TK, Gluzman-Poltorak Z, Anderson F, Basile LA.

Genet Vaccines Ther. 2009 Dec 30;7:13. doi: 10.1186/1479-0556-7-13.

13.

Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the nonhuman primate.

Hayakawa J, Ueda T, Lisowski L, Hsieh MM, Washington K, Phang O, Metzger M, Krouse A, Donahue RE, Sadelain M, Tisdale JF.

Hum Gene Ther. 2009 Jun;20(6):563-72. doi: 10.1089/hum.2008.186.

14.

Forward RNAi screens in primary human hematopoietic stem/progenitor cells.

Ali N, Karlsson C, Aspling M, Hu G, Hacohen N, Scadden DT, Larsson J.

Blood. 2009 Apr 16;113(16):3690-5. doi: 10.1182/blood-2008-10-176396. Epub 2009 Feb 2.

15.

What is the future for cord blood stem cells?

de Wynter EA.

Cytotechnology. 2003 Mar;41(2-3):133-8. doi: 10.1023/A:1024874706356.

16.

Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells?

Hawley RG.

Mol Ther. 2008 Aug;16(8):1354-5. doi: 10.1038/mt.2008.142. No abstract available.

17.

Reducing the genotoxic potential of retroviral vectors.

Ramezani A, Hawley TS, Hawley RG.

Methods Mol Biol. 2008;434:183-203. doi: 10.1007/978-1-60327-248-3_12.

18.

In vivo selection of hematopoietic stem cells transduced at a low multiplicity-of-infection with a foamy viral MGMT(P140K) vector.

Cai S, Ernstberger A, Wang H, Bailey BJ, Hartwell JR, Sinn AL, Eckermann O, Linka Y, Goebel WS, Hanenberg H, Pollok KE.

Exp Hematol. 2008 Mar;36(3):283-92. doi: 10.1016/j.exphem.2007.11.009.

19.

A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer.

Kieback E, Charo J, Sommermeyer D, Blankenstein T, Uckert W.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):623-8. doi: 10.1073/pnas.0710198105. Epub 2008 Jan 8.

20.

Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft.

Naumann N, De Ravin SS, Choi U, Moayeri M, Whiting-Theobald N, Linton GF, Ikeda Y, Malech HL.

Gene Ther. 2007 Nov;14(21):1513-24. Epub 2007 Aug 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk